Protein kodiran ovim genom je član TNF familije receptora. On je izražen na površini većine ćelijskih tipova, uključujući ćelije epitelnog i mijeloidnog porekla, ali ne na T i Blimfocitima. Ovaj protein specifično vezuje limfotoksin membransku formu (kompleks limfotoksina-alfa i limftoksina-beta se formira). Limftoksin-beta i njegov ligand učestvuju u razvoju i organizaciji limfoidnog tkiva. Aktivacija ovog proteina može da podstakne apoptozu.[1]
Ne samp da LTBR pomaže u podsticanju apoptoze, on može da dovede do oslobađanja citokinainterleukin 8. Prekomerno LTBR izražavanje u HEK293 ćelima povećava IL-8 promotorsku aktivnost, i dovodi do IL-8 oslobađanja. LTBR je takođe esencijalan za razvoj i organizaciju sekundarnih limfoidnih organa i oslobađanje drugih hemokina.[4]
Ramačandranov dijagram pokazuje da je 64.6% ostataka u poželjnom regionu.[5] Ova structura je ustanovljena putem difrakcije X-zraka. Njena rezolucija je 3.50 Å. Alfa i beta uglovi su 90 stepeni, dok je gama ugao 120 stepeni.
^Baens M, Chaffanet M, Cassiman JJ, van den Berghe H, Marynen P (1993). „Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid”. Genomics. 16 (1): 214—8. PMID8486360. doi:10.1006/geno.1993.1161.
^Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA (1994). „A lymphotoxin-beta-specific receptor”. Science (journal). 264 (5159): 707—10. PMID8171323. doi:10.1126/science.8171323.
^Chang YH, Hsieh SL, Chen MC, Lin WW (2002). „Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation”. Exp. Cell Res. 278 (2): 166—74. PMID12169272. doi:10.1006/excr.2002.5573.
^Kuai, Jun; Nickbarg Elliott; et al. (2003). „Endogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosis”. J. Biol. Chem. United States. 278 (16): 14363—9. ISSN0021-9258. PMID12571250. doi:10.1074/jbc.M208672200.
^Wu, M Y; Wang P Y; et al. (1999). „The cytoplasmic domain of the lymphotoxin-beta receptor mediates cell death in HeLa cells”. J. Biol. Chem. UNITED STATES. 274 (17): 11868—73. ISSN0021-9258. PMID10207006. doi:10.1074/jbc.274.17.11868.
^Marsters, S A; Ayres T M; et al. (1997). „Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1”. J. Biol. Chem. UNITED STATES. 272 (22): 14029—32. ISSN0021-9258. PMID9162022. doi:10.1074/jbc.272.22.14029.
Browning JL; Ngam-ek A; Lawton P; et al. (1993). „Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface.”. Cell. 72 (6): 847—56. PMID7916655. doi:10.1016/0092-8674(93)90574-A.
Crowe PD; VanArsdale TL; Walter BN; et al. (1994). „A lymphotoxin-beta-specific receptor.”. Science. 264 (5159): 707—10. PMID8171323. doi:10.1126/science.8171323.
Baens M; Chaffanet M; Cassiman JJ; et al. (1993). „Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid.”. Genomics. 16 (1): 214—8. PMID8486360. doi:10.1006/geno.1993.1161.
Baens M; Aerssens J; van Zand K; et al. (1996). „Isolation and regional assignment of human chromosome 12p cDNAs.”. Genomics. 29 (1): 44—52. PMID8530100. doi:10.1006/geno.1995.1213.
Wang X; Bornslaeger EA; Haub O; et al. (1996). „A candidate gene for the amnionless gastrulation stage mouse mutation encodes a TRAF-related protein.”. Dev. Biol. 177 (1): 274—90. PMID8660894. doi:10.1006/dbio.1996.0162.
Nakano H; Oshima H; Chung W; et al. (1996). „TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor.”. J. Biol. Chem. 271 (25): 14661—4. PMID8663299. doi:10.1074/jbc.271.25.14661.
Wu MY; Hsu TL; Lin WW; et al. (1997). „Serine/threonine kinase activity associated with the cytoplasmic domain of the lymphotoxin-beta receptor in HepG2 cells.”. J. Biol. Chem. 272 (27): 17154—9. PMID9202035. doi:10.1074/jbc.272.27.17154.
Mizushima S; Fujita M; Ishida T; et al. (1998). „Cloning and characterization of a cDNA encoding the human homolog of tumor necrosis factor receptor-associated factor 5 (TRAF5).”. Gene. 207 (2): 135—40. PMID9511754. doi:10.1016/S0378-1119(97)00616-1.
Boussaud V; Soler P; Moreau J; et al. (1999). „Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lung.”. Eur. Respir. J. 12 (4): 926—31. PMID9817170. doi:10.1183/09031936.98.12040926.
Murphy M; Walter BN; Pike-Nobile L; et al. (1999). „Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues.”. Cell Death Differ. 5 (6): 497—505. PMID10200501. doi:10.1038/sj.cdd.4400374.
Wu MY, Wang PY, Han SH, Hsieh SL (1999). „The cytoplasmic domain of the lymphotoxin-beta receptor mediates cell death in HeLa cells.”. J. Biol. Chem. 274 (17): 11868—73. PMID10207006. doi:10.1074/jbc.274.17.11868.
Yu KY; Kwon B; Ni J; et al. (1999). „A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.”. J. Biol. Chem. 274 (20): 13733—6. PMID10318773. doi:10.1074/jbc.274.20.13733.
Rooney IA; Butrovich KD; Glass AA; et al. (2000). „The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells.”. J. Biol. Chem. 275 (19): 14307—15. PMID10799510. doi:10.1074/jbc.275.19.14307.
Langeggen H, Berge KE, Johnson E, Hetland G (2003). „Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro.”. Inflammation. 26 (3): 103—10. PMID12083416. doi:10.1023/A:1015585530204.
Chang YH, Hsieh SL, Chen MC, Lin WW (2002). „Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation.”. Exp. Cell Res. 278 (2): 166—74. PMID12169272. doi:10.1006/excr.2002.5573.